1. Malignant astrocytic glioma: genetics, biology, and paths to treatment;Furnari;Genes Dev.,2007
2. R. Stupp, M.E. Hegi, W.P. Mason, M.J. van den Bent, M.J. Taphoorn, R.C. Janzer, S.K. Ludwin, A. Allgeier, B. Fisher, K. Belanger, P. Hau, A.A. Brandes, J. Gijtenbeek, C. Marosi, C.J. Vecht, K. Mokhtari, P. Wesseling, S. Villa, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J.G. Cairncross, R.-O.O. Mirimanoff, for, of, E. Groups, N. of Group, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet Oncol. 10(5) (2009) 459–466.
3. The flavonoid quercetin in disease prevention and therapy: facts and fancies;Russo;Biochem. Pharmacol.,2012
4. Anticancer potential of quercetin: a comprehensive review;Rauf;Phytother. Res.,2018
5. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition;Priyadarsini;Eur. J. Pharmacol.,2010